← Back to All Filings

Vanguard Reports Reporting Change for Moderna Holdings

Low SignificanceMarch 27, 2026 at 10:52:19 AM EDT

Moderna, Inc.

$MRNASCHEDULE 13G/ACIK: 0001682852

Subscribe to track MRNA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Vanguard Reports Reporting Change for Moderna Holdings

Company: Moderna, Inc. (null) Form: SCHEDULE 13G/A | Filed: 2026/03/27 Significance: Low

Insider: The Vanguard Group Relationship: Institutional Investor

Transaction: • Type: Reporting Realignment • Shares: 0 reported (due to disaggregation) • Owned After: 0

Key Insight: Vanguard reports 0% ownership due to an internal realignment and disaggregation of subsidiary reporting, not necessarily a liquidation of the position.

Market Context: Administrative filing updating beneficial ownership reporting structure for the $20.29B biotech company.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: Moderna, Inc.

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Vanguard Group has filed an amendment reporting 0 shares beneficially owned, explicitly citing an internal realignment and disaggregation of reporting rather than a market sale.
  • Market Impact: Neutral - This is an administrative change in how Vanguard reports holdings, not a signal of a massive sell-off.

Company Information

FieldValue
CompanyModerna, Inc.
CIK0001682852
IndustryBiological Products
Market Cap$20.29 Billion
Shares Outstanding394,940,000

Insider Information

FieldValue
NameThe Vanguard Group
CIK0000102909
TypeInstitutional Investment Manager

Transaction Details

FieldValue
Form TypeSCHEDULE 13G/A
Event Date2026-03-13
Shares Owned After0
Ownership %0%

Financial Impact Assessment

Transaction Materiality

  • Reported Ownership Change: The filing shows a drop to 0 shares (0% ownership).
  • Context: The filing includes a critical footnote: "On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment... certain subsidiaries... will report beneficial ownership separately... The Vanguard Group, Inc. no longer has... beneficial ownership over securities beneficially owned by such subsidiaries."
  • Materiality: While the number change is high, the economic materiality is low because the shares likely remain within Vanguard funds, just reported differently.

Impact Evaluation

  • Market Cap Context: For a $20.29B company, a complete exit by Vanguard would be a massive liquidity event. The lack of corresponding volume or price action confirms this is administrative.
  • Ownership Concentration: This filing technically removes The Vanguard Group (parent) as a >5% holder on paper, but the aggregate holdings of Vanguard funds likely remain significant.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The filing is purely administrative. Algorithms scraping only the "0 shares" number might briefly misinterpret this, but human analysis confirms it is a reporting structure change (disaggregation) mandated by SEC releases, not a bearish exit.

Volume & Sentiment

  • Expected Volume Impact: Negligible.
  • Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

  • Regulatory Note: The filing cites SEC Release No. 34-39538 regarding the disaggregation of business divisions for beneficial ownership reporting.
  • Timing: The event date listed is March 13, 2026, with the filing occurring on March 27, 2026.
Topics:#SECFiling#Moderna#Vanguard#InstitutionalHoldings#Form13G#Biotech#MarketAnalysis#RegulatoryCompliance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.